ALSAⓇ Gel Filler의 임상적 이용과 문제점 = Clinical Use & Problems of ALSAⓇ Gel Filler

다국어 초록 (Multilingual Abstract)

As increasing demands for facial soft tissue augmentation by injection or minimal invasive procedures,filler injection has become a popular and proper method for patients’ demands. Autologous substance filler is safe and has no side effects, proceeded with the patient’s own blood plasma.
From December 2009 to March 2010, subjects were total of 52 patients. Chief complaints of wrinkle on facial parts were extensive. Most patients received multiple injections on several facial parts.
Blood samples taken from the patients were put in a centrifuge to separate plasma. Seprerated plasma was heated in 100 with ALSA (Alamouti and Sattler) system. ALSA gel filler was injected in the patients’ wrinkles and depressed areas.
A week after the ALSA gel filler injection, most of them were satisfied. A month later, satisfaction was relatively high. But after 3 months, inquiry results changed, the number of unsatisfied patients increased. Because of absorption of injected ALSA gel filler.
ALSA had less side effects than other fillers. ALSA could be used continuously, because its component was patient’s own blood plasma. However, compare to other fillers, duration was relatively short. More research needs to be performed to increase the duration period and supplement the shortcomings. (Archives of Aesthetic Plastic Surgery 17: 159, 2011)

참고문헌 (Reference)

1 Kim WS, "The study of duration and safeness of plasmagel filler (hairless mouse)" 2009

2 Burres S, "Soft-tissue augmentation with Fascian" (28) : 101-, 2001

3 Humble G, "Soft tissue augmentation with Sculptra" 20 : 157-, 2004

4 Inamed Corporation, "Prodect Information Sheet on Cosmo Derm and CosmoPlast" Inamed Corp 2003

5 Nicolau PJ, "Long-lasting and permanent fillers: biomaterial influence over host tissue response" 119 : 2271-, 2007

6 Eppley BL, "Injectable soft-tissue fillers: clinical overview" 118 : 98e-, 2006

7 Buck DW, "Injectable fillers for facial rejuvenation: a review" 62 : 11-, 2009

8 Lupo MP, "Beddingfield FC 3rd.: Effectiveness of Juvederm Ultra Plus dermal filler in the treatment of severe nasolabial folds" 121 : 289-, 2008

9 Cohen SR, "Artecoll: A long- lasting injectable wrinkle filler material: report of a controlled, randomized, multicenter clinical trial of 251 subjects" 114 : 964-, 2004

10 Broder KW, "An overview of permanent and semipermanent fillers" 118 (118): 7S-, 2006

11 Christensen L, "Adverse reactions to injectable soft tissue permanent fillers" 29 : 34-, 2005

12 Carruthers JD, "Advances in facial rejuvenation: Botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations" 121 (121): 5s-, 2008

13 Fagien S, "A brief overview and history of temporary fillers: Evolution, advantages, and limitations" 120 (120): 8s-, 2007